TACE combined with IMRT for the treatment of advanced hepatocellular carcinoma: observation of its curative effect
10.3969/j.issn.1008-794X.2017.09.007
- VernacularTitle:TACE联合调强放疗治疗晚期肝癌的疗效观察
- Author:
Delian CHEN
1
;
Jianchao HU
;
Huihong JIANG
;
Zhenqian XU
;
Mingcong CHEN
Author Information
1. 317502,浙江 台州市肿瘤医院肿瘤内科
- Keywords:
primary hepatocellular carcinoma;
intensity modulated radiation therapy;
transcatheter arterial chemoembolization;
arterial infusion;
chemoembolization
- From:
Journal of Interventional Radiology
2017;26(9):799-802
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the curative effect of transcatheter arterial chemoembolization (TACE) combined with intensity modulated radiation therapy (IMRT) in treating advanced hepatocellular carcinoma (HCC),and to discuss the occurrence of adverse events.Methods A total of 59 patients with advanced HCC were enrolled in this study.The patients were randomly divided into TACE plus IMRT group (study group,n=30) and TACE group (control group,n=29).The early tumor response rate,progression free survival (PFS),median survival time (mST),and adverse reactions were analyzed.Results The early tumor response rate in the study group was 60.0％,which was significantly higher than 34.4％ in the control group (P=0.043).PFS of the study group was 260 days,which was remarkably higher than 195 days of the control group (P=0.006).The mST was 468 days in the study group,which was 431 days in the control group (P=0.195).In the study group,2 patients developed severe liver function damage,which was improved after active liver protection therapy for more than 20 days.Conclusion For the treatment of advanced HCC,TACE combined with IMRT can improve early tumor response rate and prolong PFS time,moreover,its adverse reactions can be well tolerated by patients.
